CCC
KTTA icon

Cable Car Capital’s Pasithea Therapeutics KTTA Stock Holding History

Cable Car Capital’s Portfolio KTTA Stock Details KTTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$895K Buy
1,206,379
+706,379
+141% +$591K 0.31% 65
2025
Q4 		$645K Buy
+500,000
New +$439K 0.02% 65

Other funds holding KTTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $268M AUM 158.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Cable Car Capital's KTTA Position: Q1 2026 in Review

Cable Car Capital increased its Pasithea Therapeutics (KTTA) stake by 141% in Q1 2026, buying an estimated $591K and bringing the position to 1,206,379 shares worth $895K. The position accounts for 0.31% of the portfolio, ranked #65.

Cable Car Capital first reported a position in KTTA in Q4 2025 and has held it in 2 quarters since. 21 funds tracked by Wall St. Rank hold KTTA as of Q1 2026.

  • Cable Car Capital held 1,206,379 shares of Pasithea Therapeutics worth $895K as of Q1 2026.
  • Cable Car Capital bought 706,379 Pasithea Therapeutics shares in Q1 2026, an estimated $591K.
  • Pasithea Therapeutics made up 0.31% of Cable Car Capital's portfolio in Q1 2026, its #65 holding.
  • Cable Car Capital first reported a position in Pasithea Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 21 funds tracked by Wall St. Rank held Pasithea Therapeutics as of Q1 2026.

Based on Cable Car Capital's 13F filing for Q1 2026, filed 15 May 2026.